Abbvie Inc (NYSE:ABBV)
| 100.47 Delayed Data As of Jul 15 |  +1.60 / +1.62%Today’s Change | 62.55 Today|||52-Week Range 100.69 | +13.47% Year-to-Date |
ABBV Regular Dividend: ABBV began trading ex-dividend on 07/14/20. A $1.18 dividend will be paid to shareholders of record as of 07/15/20.
Latest ABBV News | Press Releases
| 3 Top Biotech Stocks to Watch in July Jul 09 / MotleyFool.com - Paid Partner Content | Got $5,000? Buy These 3 High-Yield Dividend Stocks That Are Money Machines Jul 05 / MotleyFool.com - Paid Partner Content |
| Better Buy: AbbVie vs. Biogen Jul 08 / MotleyFool.com - Paid Partner Content | Better Coronavirus Stock: Eli Lilly or AbbVie? Jul 03 / MotleyFool.com - Paid Partner Content |
| 3 Best-Performing Dividend Aristocrats in the First Half of 2020: Are They Buys Now? Jul 07 / MotleyFool.com - Paid Partner Content | 5 High-Yield Dividend Stocks to Watch Jul 03 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 98.87 |
| Today’s open | 99.98 |
| Day’s range | 98.82 - 100.48 |
| Volume | 5,661,647 |
| Average volume (3 months) | 11,512,443 |
| Market cap | $170.6B |
Data as of 4:26pm ET, 07/15/2020
Growth & Valuation
| Earnings growth (last year) | +44.28% |
| Earnings growth (this year) | +17.78% |
| Earnings growth (next 5 years) | +4.29% |
| Revenue growth (last year) | +1.57% |
| P/E ratio | 17.8 |
| Price/Sales | 3.95 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +1.56 | +0.95% |
| PFEPfizer | +0.48 | +1.36% |
| MRKMerck | +1.16 | +1.48% |
| NVSNovartis | +0.42 | +0.48% |
Data as of 4:47pm ET, 07/15/2020
Financials
| Next reporting date | July 31, 2020 |
| EPS forecast (this quarter) | $2.20 |
| Annual revenue (last year) | $33.3B |
| Annual profit (last year) | $7.8B |
| Net profit margin | 23.57% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
